Calling migraine “just a bad headache” undersells what is actually a neurological disease. A migraine attack can involve pain, but it can also involve visual disturbances, nausea, extreme sensitivity to light and sound, and a level of disability that a typical headache does not produce.
The most recognizable feature of migraine is throbbing or pulsating head pain, often on one side, frequently accompanied by nausea and sensitivity to light or sound. But migraine is a broader neurological condition than pain alone, involving distinct attack phases and a range of non-headache symptoms.
This guide moves from recognizing migraine symptoms and understanding what causes them, through diagnosis and treatment, and into the emerging therapy landscape reshaping how migraine is managed.
Migraine in Plain English
Migraine is a neurological condition characterized by recurrent attacks that can involve headache along with a range of non-headache symptoms, including sensory disturbances and nausea. It differs from a generic headache in both its underlying biology and its typical symptom pattern.
Where a tension headache might cause mild, generalized discomfort, a migraine attack often significantly disrupts a person’s ability to function during the episode.
How a Migraine Attack Can Feel
Migraine attacks often progress through recognizable phases, though not everyone experiences each phase, and the pattern can vary between individuals and between attacks.
Prodrome
The prodrome phase can occur hours to days before headache onset and may include fatigue, mood changes, food cravings, yawning, or difficulty concentrating.
Aura
Aura involves temporary neurological symptoms, most commonly visual disturbances like flashing lights or blind spots, though sensory or speech-related symptoms can occur as well. Not everyone with migraine experiences aura, and many people have migraine without aura entirely.
Headache Phase
The headache phase typically involves throbbing or pulsating pain, often on one side of the head, along with nausea, vomiting, and heightened sensitivity to light or sound. Pain location and severity can vary considerably from person to person and even from attack to attack in the same individual.
Postdrome
Often called the migraine hangover, the postdrome phase can involve lingering fatigue, difficulty concentrating, or mood changes after the headache pain itself has resolved.
What Causes Migraine?
The exact cause of migraine remains complex and is not fully understood, even with substantial research progress in recent decades. Genetics, brain signaling pathways, and sensory processing systems all appear to play a role.
The trigeminovascular system and a signaling molecule called calcitonin gene-related peptide, or CGRP, are central to current scientific understanding of migraine biology. It would be inaccurate to say any single trigger is the root cause of migraine; rather, an underlying neurological susceptibility interacts with various circumstances that can provoke individual attacks.
Migraine Triggers Are Not the Same as Migraine Causes
This distinction deserves particular attention. Migraine causes involve the underlying neurological susceptibility a person has, while triggers are circumstances that may provoke an attack in someone who already has that susceptibility.
Commonly reported triggers include changes in sleep patterns, stress, hormonal fluctuations, skipped meals, dehydration, certain sensory stimuli, and weather changes. Trigger identification is highly individual, and what provokes an attack for one person may have no effect on another. It is worth being cautious about restricting entire food groups based on a weak, unconfirmed pattern, since doing so can limit daily life without clear evidence of benefit.
Who Is More Likely to Experience Migraine?
Family history and genetic susceptibility play a meaningful role in migraine risk. Age and sex-related patterns exist at a population level, though these patterns should not be treated as individual predictions.
Hormonal influences are significant for many people, and migraine frequency can shift during certain hormonal life stages. These demographic patterns describe general tendencies across populations, not guarantees for any specific individual.
When Is a Headache Actually a Migraine?
| Feature | Migraine | Tension-Type Headache | Cluster Headache |
|---|---|---|---|
| Pain quality | Throbbing or pulsating | Pressing or tightening | Severe, piercing |
| Typical location | Often one-sided | Usually both sides | Around one eye |
| Associated symptoms | Nausea, light and sound sensitivity | Usually minimal | Eye tearing, nasal congestion |
| Duration | Hours to days | 30 minutes to days | 15 minutes to 3 hours |
| Behavior during attack | Prefers rest, dark, quiet room | Can often continue activities | Restless, agitated |
Self-comparison against this table can help someone recognize patterns, but it is not a substitute for a professional diagnosis.
How Migraine Is Diagnosed
Migraine is primarily diagnosed clinically, based on a detailed medical history and characteristic symptom patterns rather than a specific blood test. A neurological examination is typically part of the evaluation, and imaging or additional testing may be considered in certain circumstances, particularly when symptoms suggest another underlying cause.
There is no single blood test that confirms ordinary migraine, which makes an accurate, detailed symptom history especially important during evaluation.
Headache Red Flags: When a “Migraine” Needs Urgent Evaluation
Certain headache features warrant urgent medical evaluation rather than assuming a typical migraine attack. These include a sudden, severe “thunderclap” headache reaching maximum intensity within seconds to minutes, new neurological deficits such as weakness or vision loss, altered consciousness, fever accompanying concerning symptoms, new headache following head trauma, and a major, unexplained change in a previously established headache pattern.
Any unusual or first-time severe headache should be evaluated by a medical professional promptly rather than managed as a typical migraine attack.
Treating a Migraine Attack When It Happens
Acute treatment approaches follow a general progression depending on attack severity. Rest and environmental modification, such as a dark, quiet room, form a first-line, non-medication approach for many people.
Acute medications include triptans, which target specific serotonin receptors, gepants, a newer medication class targeting the CGRP pathway, and ditans for appropriate patients. Antiemetic medications may be used to address nausea and vomiting during an attack. Medication overuse headache is a recognized risk when acute medications are used too frequently, and this pattern should prompt a conversation with a healthcare provider about adjusting the overall treatment approach.
Preventing Migraine Before the Next Attack
Preventive treatment is generally considered when migraine attacks are frequent enough, or disabling enough, to significantly affect a person’s quality of life. Options include oral preventive medications from several drug classes, CGRP-targeted therapies designed specifically for migraine prevention, onabotulinumtoxinA for appropriate patients with chronic migraine, neuromodulation devices, and behavioral and lifestyle approaches.
Prevention is generally about reducing attack frequency and disability rather than guaranteeing zero attacks going forward, and expectations should be set accordingly.
The CGRP Revolution in Migraine Treatment
Calcitonin gene-related peptide, or CGRP, is a molecule involved in transmitting pain signals related to migraine. Understanding its role led to the development of two major treatment categories: monoclonal antibodies designed for migraine prevention, and gepants, which can be used for either acute treatment or prevention depending on the specific medication.
This CGRP-targeted approach represents a meaningful evolution in migraine treatment, offering options developed specifically for migraine biology rather than adapted from other medical uses. Even so, response to these treatments varies between individuals, and they do not work equally well for everyone.
Building a Migraine Management Plan
A practical management pathway involves identifying an individual’s specific attack pattern, tracking symptoms and frequency over time, establishing an effective acute treatment approach, determining whether preventive treatment is appropriate, reviewing treatment response and any side effects, and reassessing the overall plan regularly with a healthcare provider.
A migraine diary or tracking app can support this process by providing organized data for discussion during medical appointments.
Companies Developing the Next Generation of Migraine Therapies
Migraine treatment research spans several distinct approaches, and understanding the general landscape helps put news about specific companies into context.
CGRP pathway treatments include both approved monoclonal antibodies for prevention and gepants used for acute or preventive treatment, developed by several pharmaceutical companies with FDA-approved products currently on the market. New acute therapies continue to be researched and developed beyond currently approved options.
Preventive therapies research includes ongoing work on both existing drug classes and novel biological targets. Neuromodulation device companies develop non-drug approaches using external devices to reduce attack frequency or severity. Novel biological target research explores mechanisms beyond CGRP that could lead to future treatment options.
Approved products should always be clearly distinguished from investigational candidates still in clinical trials. Verifying any specific company’s current development stage, indication, and regulatory status against primary sources such as FDA records or clinical trial registries is essential before relying on that information, since this landscape changes frequently. A large research pipeline does not by itself indicate treatment effectiveness.
What Could Change Migraine Treatment Next?
Emerging directions in migraine research include more precisely targeted preventive therapies, improved acute treatment options, movement toward personalized treatment selection based on individual patient characteristics, expanding noninvasive neuromodulation technology, and ongoing biomarker research aimed at better predicting treatment response.
These developments remain investigational or emerging, and readers should understand the difference between promising research and treatments currently available for clinical use.
Questions to Ask a Doctor About Migraine
- Does my symptom pattern actually fit a migraine diagnosis?
- How frequently are my attacks occurring, and are they disabling enough to warrant prevention?
- Which acute medication approach makes sense for my specific situation?
- Am I at risk for medication overuse headache based on my current usage?
- Should I be evaluated for aura-related symptoms specifically?
- What red flag symptoms should prompt me to seek urgent care?
- Are any newer CGRP-targeted therapies appropriate for my case?
Living With Migraine Beyond Medication
Consistent sleep schedules, adequate hydration, regular meals, tolerated exercise, stress management techniques, and awareness of personal trigger patterns can all support overall migraine management. These lifestyle strategies work best as a complement to appropriate medical treatment, not as a replacement for it.
Workplace accommodations, school considerations, and broader quality of life impacts are real aspects of living with migraine that deserve attention alongside the purely medical components of care.
FAQ
Q: What is a migraine?
A: Migraine is a neurological condition involving recurrent attacks that can include headache along with symptoms such as nausea, light sensitivity, and sometimes visual disturbances called aura.
Q: What are the most common migraine symptoms?
A: Common symptoms include throbbing or pulsating head pain, nausea, sensitivity to light and sound, and in some people, visual or sensory disturbances known as aura.
Q: What causes migraine?
A: Migraine involves genetic susceptibility and complex brain signaling pathways, including the trigeminovascular system and CGRP, though the exact cause remains an active area of research.
Q: What is the difference between migraine and a headache?
A: Migraine is a broader neurological condition with distinct attack phases and associated symptoms beyond pain, while a general headache typically refers only to head pain itself.
Q: What is migraine with aura?
A: Migraine with aura involves temporary neurological symptoms, most often visual disturbances, that occur before or alongside the headache phase in some, but not all, people with migraine.
Q: What are common migraine triggers?
A: Reported triggers include sleep changes, stress, hormonal fluctuations, skipped meals, dehydration, sensory stimuli, and weather changes, though triggers vary significantly between individuals.
Q: How is migraine diagnosed?
A: Migraine is diagnosed primarily through clinical history and symptom pattern assessment, along with a neurological examination, since no single blood test confirms the condition.
Q: When should a migraine be treated as an emergency?
A: Sudden severe headache, new neurological symptoms, altered consciousness, or headache following head trauma all warrant urgent medical evaluation rather than typical migraine management.
Q: What medicines can stop a migraine attack?
A: Acute treatment options include triptans, gepants, ditans, and antiemetic medications for nausea, with the appropriate choice depending on individual medical history.
Q: What medications prevent migraine?
A: Preventive options include several oral medication classes, CGRP-targeted therapies, onabotulinumtoxinA for appropriate chronic migraine patients, and neuromodulation devices.
Q: What are CGRP migraine treatments?
A: CGRP-targeted treatments include monoclonal antibodies for prevention and gepants for acute or preventive use, developed specifically to address the CGRP pathway involved in migraine.
Q: Can migraine be cured?
A: There is currently no cure for migraine, but many people achieve significant reduction in attack frequency and severity through appropriate acute and preventive treatment.
Q: What is chronic migraine?
A: Chronic migraine generally refers to experiencing headache on a significant number of days per month over an extended period, meeting specific clinical criteria distinct from episodic migraine.
Q: Are there new migraine treatments being developed?
A: Yes, ongoing research includes new acute and preventive therapies, neuromodulation devices, and novel biological targets, though these should be distinguished from currently approved treatments.
Medical Disclaimer: This article provides general information and cannot diagnose headaches or recommend an individualized treatment plan. Anyone experiencing new, severe, or changing headache patterns should seek prompt evaluation from a qualified healthcare professional.